Understanding the current EMA situation, page-3

First 3 Last

Share
Profile

Follow
Teddyward

10,067 Posts.

1067

31/03/15

00:11

Post #: 15008135
Share

Originally posted by ajbhu ↑

From my understanding, the current situation is based only on the fact that EMA has to deal with a novelty protein.

We have a Medical Device that is VitroGro.

We live in Europe and we have asked to a local health authority what can be our case based on available informations.

The answer is the following:
In general, the common cases that have to been approved by EMA CHMP is a Device only or a Medical ancillary product.
And here come the issue.
We have a fantastic product that has both characteristics in one item. This is a huge innovation to current practice, but in the meantime create the regulatory hassle to approve two items in one item.

Let's explain.

We have a scaffold (gel) that to cure hard to heal wounds has two elements.
One is Vitronectin that bind directly with the tissue and is already in our body and in our case is acting as a Device. (Practically, the gel binding with the existing skin tissue create the optimal sterile environment for skin cell reproduction).
The other element available in VitroGro is the Ancillary Medicine and this is IGF-1, that operate as a medicine and provide the tissue replication for closing the Hard to Heal Wounds.

Therefore, being a Medical Device with two properties in one (quite unique scenario as EMA has never had such a case) is in need to further get some documentation (to be made in laboratory) to properly regulate the Medical Device with both properties.

This is the reason of the additional questions.

Nobody has ever challenged the curative properties of the Medical Devices, that based on the successful clinical trials with Prof. Hardings have demonstrated to be unique in results and substantially improving patient health.

But still the product need to have proper labelling, and is fully understandable, as in the end in the Hospitals, Pharmacies and Health Providers will be essential to know specifically the storage duration of the product (in the label).

The May SWAP meeting will be oriented to build a platform of questions and answers that will satisfy the regulators to approve in the current year the product with a Scientific Opinion that cover the full spectrum, including the ancillary medicine IGF-1 that is in VitroGro.

In conclusion, this is now purely a mutual step that is needed to get final approval.

Expand

Have you had this feedback from discussion with TIS or broker?

TIS Price at posting: 11.0¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

VMM

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

AAU

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

AII

Inside the depths of Panasqueira: A legacy carved in rock

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

CWX

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

LIS

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

ILU

Rare earths stocks surge as Pentagon buys big stake in US REE miner

Trump just dropped a 200% tariff bomb. Here's how to cash in

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Understanding the current EMA situation, page-3

Top Stories

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

Inside the depths of Panasqueira: A legacy carved in rock

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

Rare earths stocks surge as Pentagon buys big stake in US REE miner

Trump just dropped a 200% tariff bomb. Here's how to cash in

Featured News